Evidence mapPaperPMID 40965151Full record

ArticleDisease models & mechanisms2025

Unravelling γδ T-cell dysregulation in the gut and its implications for immune-mediated diseases.

Dilys Santillo, Evangelos Bellos, Vanessa Sancho-Shimizu

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dilys SantilloSection of Paediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London SW7 2AZ, London, UK.ORCID 0009-0004-3966-4952
Evangelos BellosSection of Paediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London SW7 2AZ, London, UK.
Vanessa Sancho-ShimizuSection of Paediatric Infectious Disease, Department of Infectious Disease, Faculty of Medicine, Imperial College London SW7 2AZ, London, UK.ORCID 0000-0002-3519-0727

Funding

European CommissionMedical Research Council MR/X023990/1
6 · The paper itself

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare condition associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and characterised by systemic inflammation and T-cell dysfunction. A subset of patients with MIS-C were found to harbour rare variants in the gene BTNL8 that disrupt BTNL8-BTNL3 heterodimer formation, likely leading to inadequate γδ T-cell regulation and subsequent disrupted gut homeostasis. MIS-C shares clinical features with Kawasaki disease and similar mechanisms of pathogenesis with inflammatory bowel disease, despite these diseases being clinically distinct entities. We explore the common link between these diseases: the potentially critical role gut immunity plays in the initiation and persistence of disease through the tight regulation of γδ T cells via BTNL8 and BTNL3. Understanding the role of BTNL8 in the context of the overlap between these conditions may aid preventative measures and treatment of these conditions.

Indexed as

COVID-19Gastrointestinal TractImmune System DiseasesReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAnimalsButyrophilinsHumansSARS-CoV-2Systemic Inflammatory Response SyndromeButyrophilinsReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID40965151
PMCPMC12486229

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.